Aspivix, represented by their US General Manager, Ikram Guerd, has been awarded the StewardGård Award 2025 by the Swiss-American Chamber of Commerce. This distinction, presented in Los Angeles, celebrates companies that demonstrate exceptional innovation, leadership, and impact, recognizing achievements that strengthen and inspire both the Swiss and American business communities.

This award recognise Aspivix commitment to transforming women’s healthcare through compassionate, patient-centered gynecology. The company’s breakthrough device, CAREVIX®, offers a modern, gentle alternative to the traditional tenaculum used during gynecological procedures such as IUD placement. Instead of sharp, traumatic clamping, Aspivix’s technology uses a soft, suction-based atraumatic approach designed to significantly reduce pain, bleeding, and anxiety for patients.

Just two months after its official US launch, Aspivix’s impact in improving patient experience and supporting clinicians has been recognized among the most innovative companies in the Southern California region. This award underscores the company’s growing influence and its mission to bring a new standard of care to gynecology.